Empirical Financial Services LLC d.b.a. Empirical Wealth Management lowered its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,181 shares of the company’s stock after selling 617 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Colgate-Palmolive were worth $1,107,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. KFG Wealth Management LLC grew its holdings in Colgate-Palmolive by 6.9% during the 4th quarter. KFG Wealth Management LLC now owns 8,704 shares of the company’s stock worth $791,000 after acquiring an additional 564 shares during the period. Jamison Private Wealth Management Inc. boosted its holdings in Colgate-Palmolive by 531.7% during the fourth quarter. Jamison Private Wealth Management Inc. now owns 3,670 shares of the company’s stock worth $334,000 after buying an additional 3,089 shares during the last quarter. Toth Financial Advisory Corp grew its position in shares of Colgate-Palmolive by 1.6% during the 4th quarter. Toth Financial Advisory Corp now owns 55,878 shares of the company’s stock worth $5,080,000 after buying an additional 883 shares during the period. CFS Investment Advisory Services LLC increased its stake in shares of Colgate-Palmolive by 10.1% in the 4th quarter. CFS Investment Advisory Services LLC now owns 13,114 shares of the company’s stock valued at $1,192,000 after acquiring an additional 1,203 shares during the last quarter. Finally, Grimes & Company Inc. raised its position in shares of Colgate-Palmolive by 3.4% in the 4th quarter. Grimes & Company Inc. now owns 12,503 shares of the company’s stock valued at $1,137,000 after acquiring an additional 410 shares during the period. Institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have commented on CL shares. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. UBS Group decreased their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. Finally, StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $101.11.
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.34% of the company’s stock.
Colgate-Palmolive Stock Performance
Shares of CL stock opened at $89.92 on Wednesday. The company has a fifty day moving average price of $91.74 and a two-hundred day moving average price of $97.40. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The stock has a market cap of $73.47 billion, a P/E ratio of 25.77, a P/E/G ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.22%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is diluted earnings per share (Diluted EPS)?
- What Does the Future Hold for Eli Lilly?
- How to Use the MarketBeat Dividend Calculator
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.